The 12th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2025 to bring you the latest advances in the combination product drug delivery space.
As part of the leading Injectable Drug Delivery Series, the 2025 conference will be bigger and better than ever, bringing you 3 days of expertise, comprising of a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference with morning keynote plenaries and parallel afternoon topic streams addressing the industry’s hottest topics through case studies and industry insights.
This event will not only bring you key insights needed to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in April 2025!
Featured Speakers
- Aditya Nair, Packaging Engineer, Pfizer
- Ajit D'Souza, Executive Director, Drug Delivery and Devices, Eli Lilly
- Alfredo Ricci, CEO, Althena Medical
- Alie Jahangir, Head of Quality, Device and Combination Products, Biogen
- Amardeep Hoonjan, Director Device R&D Lead, Biocompatibility Group, AbbVie
- Bharat Arora, Director, Global Combination Products Quality, Moderna
- Confirmed Senior Representative, AbbVie
- Confirmed Senior Representative, BioPhorum
- Confirmed Senior Representative, Biophorum
- Conor O'Neill, Head of Packaging Development and Design, GSK
- Craig Voellmicke, Director of Sales, Suttons Creek, Inc.
- Daniel Davenport, Associate Director Early Engagement and Deviceability, GSK
- Dany Doucet, Director Early Engagement and Deviceability, GSK
- David Vazquez, Head SaMD Legal Manufacturing, Pfizer
- Duncan Paterson, Senior Director, AstraZeneca
- Ellie Younger, Associate Principal Engineer, AstraZeneca
- Fletcher Dix, Sr. Process Characterization and Technology Engineer, Regeneron Pharmaceuticals
- Gretchen Piwinski, Sr Manager Combination Product Development, Regeneron
- Guangli Hu, Director, Merck & Co., Inc.
- James P. Wabby, Global Head, Regulatory Affairs - Emerging Device Technologies and Combination Products, AbbVie
- Jayne Gavrity, Senior Device Engineer, AstraZeneca
- Joanita Akole Lamien, Sr. Human Factors Engineer, Regeneron Pharmaceuticals
- Joyce Zhao, Director, Combination Product Development, Takeda Pharmaceuticals
- Kinsuk Shah, Sr. AD Combination Product Steward, Boehringer Ingelheim
- Lisa Ray, Executive Director Program Management – Delivery, Device & Connected Solutions, Eli Lilly
- Mark DeStefano, Director, Combination Products and Device R&D, Teva Pharmaceuticals
- Mark Hassett, Vice President of Business Development, Credence MedSystems
- Martin McLoughlin, Head of Device Development, Bristol Myers Squibb
- Matt Marber, Senior Usability Engineer, Novo Nordisk
- Megan Heft, Director, Device Development, AstraZeneca
- Mike Wallenstein, Novartis Global Head RA Medical Devices, Combination Products & Precision Medicine, Novartis Pharma AG
- Natalie Berry, Combination Product Development Engineer, Pfizer
- Nicholas Mandala, VP Medical Device & Combination Product Technology, Pfizer
- Ning Yu, Executive Director, Device and Combination Product Development, Astria Therapeutics
- Ram Halthore, Director of Engineering, Merck
- Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
- Sarah Fairfield, Associate Director, RA Device and Combination Products Digital Device and Software, AbbVie
- Soumen Das, Medical Device Qualification Lead & Associate Scientific Fellow, Takeda Pharmaceutical Company Limited
- Sriman Banerjee, Head of Packaging Development & CDE, Takeda Pharmaceuticals
- Subhi Saadeh, Senior Manager, Combination Products QA, Gilead
- Sujit Basu, Vice President & Head, Pharmaceutical Development, Ionis
- Theresa Scheuble, Head of Design & Innovation, Johnson & Johnson
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Sheraton Boston Hotel
39 Dalton Street,
Boston, MA, USA
